AyurDatta's curated ecosystem connects you with best-in-class partners across clinical operations, safety, analytics, and manufacturing — without months of vendor evaluation.
Learn how we engageBiopharma innovators waste months evaluating service providers:
The consequence? Delayed timelines, mismatched vendor capabilities, and costly do-overs when partnerships fail.
We've done the hard work of vetting, qualifying, and building relationships with best-in-class partners across every function you need. We know which partners excel in which situations, and we have no financial incentive to recommend the wrong fit.
These trusted partnerships represent years of proven collaboration, delivering specialized expertise exactly when our clients need it.
Pharmacovigilance & QPPV Partner
A specialist pharmacovigilance consultancy led by Dr. Med. Dnyaneshwar Arjun Sanap, providing QPPV services, PV system build, audits, and aggregate reporting support for global programs.
View DSPV Partner Profile
Strategic Consulting & AI Automation Partner
AI-powered technology solutions for healthcare and life sciences, providing compliant process optimization, strategic consulting, and digital transformation services to accelerate clinical operations.
View CliniDash Partner ProfileAre you a best-in-class service provider in clinical development, technology, or life sciences? Join our curated partner ecosystem and gain access to biopharma clients seeking strategic, vendor-agnostic guidance for their programs.
Discuss PartnershipWithout AyurDatta:
3–6 months evaluating vendors, attending sales pitches, checking references, negotiating contracts.
With AyurDatta:
2–4 weeks from needs assessment to partner selection with pre-vetted options and negotiated frameworks.
Without AyurDatta:
Hope your vendor vetting was thorough and discover issues mid-engagement.
With AyurDatta:
Partners have been stress-tested on real programs, and we provide ongoing oversight to catch issues early.
Without AyurDatta:
Pay retail pricing and spend budget on trial-and-error with wrong-fit vendors.
With AyurDatta:
Access framework pricing and avoid costly restarts by getting the right fit the first time.
Without AyurDatta:
Manage 5–10 separate vendor relationships with no coordination.
With AyurDatta:
Single point of accountability for orchestrating your full partner ecosystem.
We don't just send you a list — we actively facilitate partnerships from needs assessment through ongoing management.
We understand your therapeutic area, trial phase, geographic scope, timeline, budget, and quality vs. cost trade-off preferences.
3–5 partner recommendations with comparative analysis, capability matrices, reference checks, and indicative pricing estimates.
Direct introductions to partner leadership, joint scoping calls, pre-negotiated SOW templates, and contract negotiation support.
Monthly check-ins, issue escalation, performance scorecarding against KPIs, and continuous optimization recommendations.
Access specialized capabilities across every function critical to clinical development success — all pre-vetted, performance-tested, and ready to deploy.
Mid-sized CROs (200–2,000 employees) that provide the quality of large players without the bureaucracy:
For specific capabilities that general CROs often lack:
DSPV brings 15+ years of global pharmacovigilance expertise with a focus on oncology, rare diseases, and advanced therapies. Their founding partners have managed safety for 100+ clinical trials and supported 20+ regulatory submissions across FDA, EMA, and PMDA.
View DSPV Full Profile →No. Our business model is built on client fees, not vendor commissions. This ensures our recommendations are always in your best interest.
We're happy to work with your existing partners. We can provide independent assessments of their performance and fill gaps where needed.
Absolutely. Once we've facilitated the introduction and initial scoping, you work directly with the partner. We remain available for issue escalation and performance monitoring if needed.
If a partnership fails within the first 90 days due to capability misrepresentation, we'll facilitate a replacement at no additional cost for the re-selection process.
We conduct quarterly reviews of all partners, soliciting feedback from clients and monitoring industry developments. We proactively sunset relationships that no longer meet our standards.
We maintain relationships with all major CROs but typically recommend them only for late-stage (Phase IIb/III) global trials where scale is essential. For most of our clients, mid-sized specialists provide better fit.
We're selective about who we bring into our ecosystem. Ideal partners share our commitment to quality, transparency, and innovation.
Company overview, core capabilities, therapeutic areas served, and sample case studies.
Review of materials, reference checks, and assessment of strategic fit and capability gaps.
Mutual due diligence, commercial terms development, and joint client engagement pilots.
Partner profile development, integration into vendor selection framework, and joint go-to-market planning.
Let us connect you with the right partners in weeks, not months.